ZEKE CAPITAL ADVISORS, LLC - VALLON PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

VALLON PHARMACEUTICALS INC's ticker is VLON and the CUSIP is 92023M101. A total of 11 filers reported holding VALLON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ZEKE CAPITAL ADVISORS, LLC ownership history of VALLON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$28,000
-68.9%
15,0000.0%0.00%
-80.0%
Q4 2021$90,000
-37.9%
15,000
-25.0%
0.01%
-37.5%
Q3 2021$145,000
-11.0%
20,000
-33.3%
0.01%
-20.0%
Q2 2021$163,000–30,000–0.01%–
 Download
Other shareholders
VALLON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 15$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 21,569$13,0000.00%
CITIGROUP INC 6,000$4,0000.00%
North Star Investment Management Corp. 1,750$1,0000.00%
MORGAN STANLEY 50$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 35,798$23,0000.00%
Tower Research Capital LLC (TRC) 12,040$8,0000.00%
Renaissance Technologies 78,888$50,0000.00%
VANGUARD GROUP INC 23,464$15,0000.00%
View complete list of VALLON PHARMACEUTICALS INC shareholders